MCM
AGN

Moore Capital Management’s Allergan plc AGN Stock Holding History

Moore Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,000
Closed -$2.52M – 251
2016
Q4 		$2.52M Hold
12,000
– – 0.08% 127
2016
Q3 		$2.76M Hold
12,000
– – 0.1% 123
2016
Q2 		$2.77M Buy
+12,000
New +$2.77M 0.11% 129

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Moore Capital Management's AGN Position: Q2 2020 in Review

Moore Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 210,000 shares — an estimated $37.2M sold.

Moore Capital Management first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $38.2M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Moore Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Moore Capital Management sold 210,000 Allergan plc shares in Q2 2020, an estimated $37.2M.
  • Moore Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
  • Moore Capital Management's Allergan plc position peaked at $38.2M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Moore Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.